Raymond N. DuBois, MD, PhD, FAACR, is being honored with a 2022 AACR Distinguished Service Award, which recognizes individuals whose extraordinary work exemplifies the AACR’s mission to prevent and cure all cancers through research, education, communication, collaboration, science policy and advocacy, and funding for cancer research.

DuBois will present his award lecture at 4:30 p.m. on Tuesday, April 12, in Room 265-268 at the convention center. He is being honored for elucidating the role of cyclooxygenase 2 (COX-2) in colon cancer and the contributions of the lipid metabolite prostaglandin E2 (PGE2) to tissue inflammation in the etiology of colon cancer. His groundbreaking work led to the discovery of a COX-2 inhibitor that reduces polyp formation in patients with familial adenomatous polyposis.

DuBois is being recognized for his significant contributions to not only the cancer field at large, but also to the AACR, including his past AACR presidency, his work as editor-in-chief of the journal Cancer Prevention Research, and his service as president and chair of the AACR Foundation Board of Trustees.

“The AACR is proud to present a 2022 Distinguished Service Award to Dr. DuBois, whose leadership and selfless dedication to scientific progress has helped countless cancer patients, survivors, and their families, both in the United States and around the world,” said AACR CEO Margaret Foti, PhD, MD (hc). “We are grateful for his pioneering contributions to cancer research and biomedical science, and look forward to celebrating him at the AACR Annual Meeting 2022.”

DuBois is director of the Medical University of South Carolina Hollings Cancer Center and executive chairman of the board of The Mark Foundation for Cancer Research.

[sub-post-content]